MAY 13, 2016 6:11 AM PDT

C9ORF72 Repeat Expansion Impairs Protein Degradation in FTD/ALS

WRITTEN BY: Cassidy Reich
Alzheimer’s disease gets most of the press for neurodegeneration, but it is not the only devastating neurodegenerative disease out there. Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are both less prevalent than Alzheimer’s, but they present their own issues and challenges. ALS affects ~30,000 people in the U.S. and is relatively fast-moving, with an average life expectancy from time of diagnosis of 2-5 years. FTD is slightly more prevalent, affecting ~50,000-60,000 in the U.S. What is interesting about FTD is that the average age of diagnosis is 57, a full 13 years earlier than the average age of Alzheimer’s diagnosis. ALS is characterized by the degeneration of motor neurons and FTD is more cognitive and behavioral deficits, but there is some evidence that these two diseases share an underlying pathology, specifically the G4C2 repeat expansions in C9ORF72.
 

ALS and FTD that are caused by these repeat expansions are collectively referred to as c9FTD/ALS. This repeat expansion can be transcribed into sense and antisense mRNA which is then translated to produce a series of proteins of repeating dipeptides. Using the single letter code for amino acids, these dipeptides are GP, GA, GR, PA, and PR. Researchers at the Mayo Clinic Department of Neuroscience were especially interested in the role the poly(GA) peptides play in disease pathogenesis.

In the brains of patients with c9FTD/ALS, there are abundant poly(GA) inclusions in the cytoplasm of neurons. Applying poly(GA) to cultured cells or primary neurons induced toxicity, lending validity to their theory that poly(GA) aggregates have a strong contribution in c9FTD/ALS disease pathology. To study the mechanisms behind poly(GA)’s pathological role in c9FTD/ALS, the researchers used a mouse model that specifically looks at poly(GA) with no other pathologies. To create this mouse model, they used an adeno-associated viral (AAV) vector to express poly(GA) in the mouse central nervous system. They also wanted to specifically look at the pathological role of aggregated poly(GA), so they created a poly(GA) mutant [poly(GA)mut] that is incapable of aggregating. The poly(GA)-expressing mice had a very strong neurodegeneration phenotype, with abundant poly(GA) inclusions; neuronal loss in the cortex, hippocampus, and cerebellum; and behavioral, motor, and memory deficits. The poly(GA)mut mice had none of these signs of neurodegeneration, suggesting that poly(GA) pathology is dependent on poly(GA) aggregation.
 
Visible inclusions in neurons from the poly(GA) mice.

The most important finding from this paper though is the discovery that poly(GA) aggregation leads to HR23 pathology. HR23A and HR23B are proteins that are involved in DNA repair and in shuttling proteins that are marked for degradation with ubiquitin to the proteasome. The researchers saw that ubiquitinated proteins and HR23 proteins accumulate in poly(GA) inclusions. The model they propose is that poly(GA) aggregates sequester HR23 proteins, leading to an accumulation of ubiquitinated proteins in the cytoplasm. Have a build-up of proteins that need to be degraded is very cytotoxic.

This paper is extraordinarily detailed and I have barely scratched the surface of the experiments that the researchers did. The main takeaway is that poly(GA) aggregation contributes significantly to c9FTD/ALS neurodegeneration by initiating HR23 pathology and impairing the ubiquitin-proteasome system. It also hints at the possibility of targeting the poly(GA) monomers to inhibit their aggregation as a therapeutic strategy. That kind of therapy is a long way away, but research like this is the first step.  

Sources: Nature Neuroscience, ALS, and FTD
About the Author
Bachelor's (BA/BS/Other)
Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
DEC 23, 2022
Health & Medicine
Study Identifies Three Metabolites That Can be Used as Coffee Biomarkers
Study Identifies Three Metabolites That Can be Used as Coffee Biomarkers
Researchers from the Leibniz Institute for Food Systems Biology at the Technical University of Munich (LSB) have identif ...
DEC 23, 2022
Chemistry & Physics
The Science Behind Holiday Specs
The Science Behind Holiday Specs
Whether young or old, anyone can enjoy those fun holiday glasses that turn pinpoints of lights into fun shapes—sno ...
DEC 30, 2022
Health & Medicine
Increased Drinking Among Mothers During Pandemic
Increased Drinking Among Mothers During Pandemic
Mothers may have consumed alcohol less frequently as the COVID-19 pandemic progressed, but they engaged in more binge dr ...
JAN 19, 2023
Cardiology
Air Pollution Linked to Long-term Health Conditions
Air Pollution Linked to Long-term Health Conditions
People in areas with high pollution are more likely to have multiple long-term health conditions.
FEB 01, 2023
Microbiology
Are Viral Infections Leading to Neurodegenerative Diseases?
Are Viral Infections Leading to Neurodegenerative Diseases?
Even after decades of research, the cause of the most common form of dementia, Alzheimer's disease, is unclear. Evidence ...
FEB 02, 2023
Neuroscience
Neurons Can Smell a Threat
Neurons Can Smell a Threat
A recent study published in The Journal of Neuroscience revealed our sense of smell guide how the brain responds to a so ...
Loading Comments...